Page 728 - Cardiac Nursing

AM
49
p65
704
g
P
qxd
04.
5-7
09
/1/
7
28_
0-c
tar
Ap
L L LWB K34 0-c 28_ p65 5-7 04. qxd 7 /1/ 09 9: 49 AM P a a g e e 704 Ap tar a a
LWB
K34
LWBK340-c28_p655-704.qxd 7/1/09 9:9:49 AM Page 704 Aptara
704 PA R T I V / Pathophysiology and Management Disease
86. Wilkoff, B. L., Ousdigian, K. T., Sterns. L. D., et al. (2006). A compari- 102. Schron, E. B., Exner, D. V., Yao, Q., et al. (2002). Quality of life in the an-
son of empiric to physician-tailored programming of implantable car- tiarrhythmics versus implantable defibrillator trial: Impact of therapy and
dioverter-defibrillators. Journal of the American College of Cardiology, influences of adverse symptoms and defibrillator shocks. Circulation, 105,
48(2), 330–339. 589–594.
87. Kenny, T. (2006). The nuts and bolts of ICD therapy. Waltham, MA: 103. Wallace, R. L., Sears, S. F., Lewis, T. S., et al. (2002). Predictors of qual-
Blackwell Publishing. ity of life in long-term recipients of implantable cardioverter defibrilla-
88. Hammill, S. C., Stevenson, L. W., Kadish, A. H., et al. (2007). Na- tors. Journal of Cardiopulmonary Rehabilitation, 22, 278–281.
tional ICD registry annual report 2006—Review of the registry’s first 104. Abraham, W. T., Young, J. B., Leon, A. R., et al. (2004). Effects of car-
year, data collected, and future plans. Heart Rhythm Society, 4(9), diac resynchronization on disease progression in patient with left ven-
1260–1263. tricular systolic dysfunction, an indication for an implantable car-
89. Rasmussen, M. J., Friedman, P. A., Hammill, S. C., et al. (2002). Unin- dioverter-defibrillator, and mildly symptomatic chronic heart failure.
tentional deactivation of implantable cardioverter-defibrillators in health Circulation, 110, 2864–2868.
7
7
care settings. Mayo Clinic Proceedings, 77, 855–859. 105. Epstein, A. E., Baessler, C. A., Curtis, A. B., et al. (2007). Addendum to
90. Boston Scientific. (2006). Safety advisory: Original communication 23 “personal and public safety issues related to arrhythmias that may affect
June 2005. CRM product performance report (pp. 76–77). St. Paul, MN: consciousness: Implication for regulation and physician recommenda-
Author. tions: A medical/scientific statement from the American Heart Associa-
91. Kroll, M. W., & Tchou, P. J. (2007). Testing and programming of im- tion and the North American Society of Pacing an Electrophysiology.” A
plantable defibrillator functions at implantation. In K. A. Ellenbogen, G. scientific statement from the AHA and Heart Rhythm Society. Heart
N. Kay, C. P. Lau, et al. (Eds.), Clinical cardiac pacing, defibrillation, and Rhythm, 4(3), 386–393.
resynchronization therapy (pp. 531–557). Philadelphia: Saunders Elsevier. 106. Cambre, S., & Silverman, M. E. (1993). Is it safe to drive with an auto-
92. Allen, M. (2006). Review article: Pacemakers and implantable car- matic implantable cardioverter defibrillator or a history of recurrent symp-
dioverter defibrillators. Anesthesia, 61, 883–890. tomatic ventricular arrhythmias? Heart Disease and Stroke, 2, 179–181.
93. Epstein, A. E. (2007). Troubleshooting of implantable cardioverter- 107. Stevenson, W. G., Chaitman, B. R., Ellenbogen, K. A. et al. (2004).
defibrillator. In K. Ellenbogen, G. N. Kay, C. P. Lau, et al. (Eds.), Clini- AHA Science Advisory: Clinical assessment and management of patients
cal cardiac pacing, defibrillation, and resynchronization therapy (pp. with implanted cardioverter-defibrillators presenting to nonelectrophysi-
1063–1086). Philadelphia: Saunders Elsevier. ologists. Circulation, 110, 3866–3869.
94. McPherson, C. A., & Manthouos, C. (2004). Update in nonpulmonary 108. Lloyd, M. A., Hayes, D. L, & Friedman, P. A. (2000). Troubleshooting.
critical care: Permanent pacemakers and implantable defibrillators— In D. L. Hayes, M. A. Lloyd, & P. A. Friedman (Eds.), Cardiac pacing
consideration for intensivists. American Journal of Respiratory and Criti- and defibrillation: A clinical approach (pp. 345–451). Elmsford, NY:
cal Care Medicine, 170, 933–940. Blackwell Publishing, Inc.
95. Hayes, D. L. (2000). Electromagnetic interference and implantable de- 109. Carlson, M. D. et al. (2006). Recommendations from the Heart Rhythm
fibrillators. In D. L. Hayes, M. A. Lloyd, & P. A. Friedman (Eds.), Car- Society Task Force on Device Performance Polices and Guidelines. En-
diac pacing and defibrillation: A clinical approach (pp. 519–539). Elms- dorsed by the American College of Cardiology Foundation (ACCF) and
ford, NY: Blackwell Publishing Inc. the American Heart Association (AHA) and the International Coalition
96. Sears, S. F., Vasquez Sowell, L. D., Kuhl, E. A., et al. (2007). The ICD of Pacing and Electrophysiology Organizations (COPE). Heart Rhythm,
shock and stress management program: A randomized trial of psychoso- 3(10), 1250–1273.
cial treatment to optimize quality of life in ICD patients. Pacing and 110. Hernandez, A. F., Fonarow, G. H., Liang, L., et al. (2007). Sex and racial
Clinical Electrophysiology, 30(7), 858–864. differences in the use of implantable cardioverter-defibrillators among
97. Sears, S. F., Shea, J. B., & Conti J. B. (2005). How to respond to an im- patients hospitalized with heart failure. JAMA, 298(13), 1525–1532.
plantable cardioverter-defibrillator shock. Circulation, 111, e380–e382. 111. Smaha, L. A. (2004). The American Heart Association get with the
98. Thomas, S. A., Friedman, E., & Kao, C. W. (2006). Quality of life and guidelines program. American Heart Journal, 148(5), S46–S48.
psychological status of patients with implantable cardioverter defibrilla- 112. Goldstein, N. E., Lampert, R., Bradley, E., et al. (2004). Management of
tors. American Journal of Critical Care, 15(4), 389–398. implantable cardioverter defibrillators in end-of-life care. Annals of Inter-
99. Dougherty, C. M., Pyper, G. P., & Frasz, H. A. (2004). Description of a nal Medicine, 141, 835–838.
nursing intervention program after an implantable cardioverter defibril- 113. Rich, M. W., Curtis, A. B. for the PRICE-IV Investigators. (2007).
lator. Heart and Lung, 33(3), 183–190. Fourth pivotal research in cardiology in the elderly (PRICE-IV) sympo-
100. Pederson, S. S., Van Den Broek, K. C., & Sears, S. F. (2007). Psycho- sium—Electrophysiology and heart rhythm disorders in the elderly;
logical intervention following implantation of an implantable defibrilla- mechanisms and management. The American Journal of Geriatric Cardi-
6
tor: A review and future recommendations. Pacing and Clinical Electro- ology, 16(5), 304–314.
6
physiology, 30(12), 1546–1554. 114. Burke, M. C., Coman, J. A., Cates, A. W., et al. (2005). Defibrillation
101. Sears, S. F., & Conti, J. B. (2006). Psychological aspects of cardiac de- energy requirements using a left anterior chest cutaneous to subcuta-
vices and recalls in patients with implantable cardioverter defibrillators. neous shocking vector: Implication for a total subcutaneous implantable
American Journal of Cardiology, 98, 565–567. defibrillator. Heart Rhythm, 2, 1332–1338.